CDT Equity (CDT) Tax Rate (2022 - 2023)
CDT Equity's (CDT) quarterly Tax Rate came in at 162.42% in Q2 2023, down 12860.0% YoY from N/an in Q2 2022, and down 796.78% on a QoQ basis from 23.31% in Q1 2023.
CDT Equity (CDT) Tax Rate (2022 - 2023) Analysis & Trends
CDT Equity (CDT) has 2 years of Tax Rate data on file, last reported at 162.42% in Q2 2023.
- Quarterly Tax Rate fell 12860.0% year-over-year to 162.42% in Q2 2023, while the trailing twelve-month figure through Jun 2023 was 52.11% (changed N/A YoY) and the FY2022 annual result came in at 48.46%, changed N/A from the prior year.
- Tax Rate fell to 162.42% in Q2 2023, from 23.31% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 43.09% in Q3 2022 to a low of 162.42% in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.65 Bn | 131.79 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 86.08 Bn | 78.09 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 65.16 Bn | 59.98 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 63.25 Bn | 58.11 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 42.22 Bn | 37.12 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 31.26 Bn | 27.95 Bn | 992.69 Mn | 7.49% |
| 7 | BioNTech SE | 28.96 Bn | 10.57 Bn | 668.28 Mn | 34.12% |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | -16.71% |
| 9 | Royalty Pharma | 27.19 Bn | 26.35 Bn | - | - |
| 10 | CDT Equity | 1.65 Mn | 1.65 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -162.42% |
| Jun 30, 2023 | -162.42% |
| Jun 30, 2023 | -162.42% |
| Mar 31, 2023 | 23.31% |
| Mar 31, 2023 | 23.31% |
| Mar 31, 2023 | 23.31% |
| Dec 31, 2022 | 25.09% |
| Dec 31, 2022 | 25.09% |
| Dec 31, 2022 | 25.09% |
| Sep 30, 2022 | 43.09% |
| Sep 30, 2022 | 43.09% |
| Sep 30, 2022 | 43.09% |
| Jun 30, 2022 | -33.82% |
| Jun 30, 2022 | -33.82% |
| Jun 30, 2022 | -33.82% |